CORRELATION OF APOPTOSIS MARKERS LEVELS WITH THE DEVELOPMENT OF HEPATIC FAILURE IN MALIGNANT OBSTRUCTIVE JAUNDICE
DOI:
https://doi.org/10.15407/exp-oncology.2025.01.068Keywords:
apoptosis, jaundice, biliary decompression, hepatic failureAbstract
Obstructive jaundice (OJ) is a common diagnosis in everyday clinical practice, which requires a thorough understanding of pathophysiological changes occurring in the liver to plan ongoing treatment and predict its effectiveness in the postoperative period. The study aimed to determine the dynamics of changes in the levels of apoptosis markers (caspase-3 and BCL-2) at the time of preoperative biliary decompression (PBD) and major surgery depending on the severity of the hepatic failure (HF) and to evaluate their correlation with the severity grade of HF in patients with malignant obstructive jaundice (MOJ). Materials and Methods. The study included 104 patients with MOJ who underwent PBD. All patients were diagnosed with HF of moderate severity (n = 65) or severe HF (n = 39). During PBD and main surgical intervention, the levels of caspase-3 and BCL-2 were determined in blood serum and bile by the Sandwich-ELISA method. Results. The values of apoptosis markers in patients with moderate and severe HF were significantly different at the time of PBD and major surgery (p < 0.001). PBD significantly reduced the levels of caspase-3 and increased the levels of BCL-2 in sera of patients with MOJ and HF, which was confirmed by further intraoperative values of the indicators, p < 0.001. Imbalance of serum caspase-3 (R2 Nagelkerke = 0.553, p = 0.013) and BCL-2 (R2 Nagelkerke = 0.327, p = 0.003) levels was associated with severe HF. Conclusions. The indicators of apoptosis after PBD can serve as additional markers of the effectiveness of a patient’s treatment in the preoperative period and can be included in the diagnostic and therapeutic algorithm for patients with MOJ.
References
Liu JJ, Sun YM, Xu Y, et al. Pathophysiological consequences and treatment strategy of obstructive jaundice. World J Gastrointest Surg. 2023;15(7):1262. https://doi.org/10.4240/wjgs.v15.i7.1262
Soares PFDC, Gestic MA, Utrini MP, et al. Epidemiological profile, referral routes and diagnostic accuracy of cases of acute cholangitis among individuals with obstructive jaundice admitted to a tertiary-level university hospital: a cross-sectional study. Sao Paulo Med. J. 2019;137:491-497. https://doi.org/10.1590/1516-3180.2019.0109170919
Kurniawan J, Hasan I, Gani RA. Mortality-related factors in patients with malignant obstructive jaundice. Acta Med Indones. 2016;48:282-288. PMID: 28143989
Hong, JY, Sato EF, Hiramoto K, et al. Mechanism of liver injury during obstructive jaundice: role of nitric oxide, splenic cytokines, and intestinal flora. J Clin Biochem Nutr. 2007;40(3):184-193. https://doi.org/10.3164/jcbn.40.184
Donald W, Nicholson DW, Thornberry NA. Killer protease. Trends Biochem Sci. 1998;22(8):299-306. https://doi. org/:10.1083/jcb.140.6.1485
Xu F, Dai CL, Peng SL, et al. Preconditioning with glutamine protects against ischemia/reperfusion-induced hepatic injury in rats with obstructive jaundice. Pharmacology. 2014;93(3-4):155-165. https://doi.org/:10. 1159/000360181
Zhou M, Zhang Q, ZhaoJ, et al. Phosphorylation of Bcl-2 plays an important role in glycochenodeoxycholate-induced survival and chemoresistance in HCC. Oncol Rep. 2017;38(3):1742-1750. https://doi.org/:10.3892/or.2017.5830
Drichits ОА, Kiziukevich LS, Kapytski AV, et al. Experimental subhepatic obstructive jaundice and BCL-2 gene expression. Biol Markers Fundam Clin Med. 2019;3(2):4-5. https://doi.org/:10.29256/v.03.02.2019.escbm01
Dronov OI, Kovalska IO, Kozachuk YS, et al. Сhanges analysis of the hepatocyte apoptosis markers levels in ma- lignant obstructive jaundice complicated by cholangitis. Wiad Lek. 2023;76(3):560-567. https://doi.org/:10.36740/ WLek202303115
National Cancer Institute Available from: https://unci.org.ua/standarty-diagnostyky-ta-likuvannya/
National Comprehensive Cancer Network (NCCN Guidelines) Available from: https://www.nccn.org/guidelines/ category_1
Donelli MG, Zucchetti M, Munzone E, et al. Pharmacokinetics of anticancer agents in patients with impaired liver function. Eur J Cancer. 1998;34:33-46. https://doi.org/10.1016/s0959-8049(97)00340-7
Tchambaz L, Schlatter C, Jakob M, et al. Dose adaptation of antineoplastic drugs in patients with liver disease. Drug Safety. 2006;29(6):509-522. https://doi.org/10.2165/00002018-200629060-00004
Xing TJ. Clinical classification of liver failure: consensus, contradictions and new recommendations. J Clin Gastro- enterol Hepatol. 2017;1(2). https://doi.org/10.21767/2575-7733.1000016
Tokyo Guidelines recommendation, 2018. Available from: http://onlinelibrary.wiley.com/doi/10.1002/jhbp.512/full
Shen Z, Zhang J, Zhao S, et al. Preoperative biliary drainage of severely obstructive jaundiced patients decreases overall postoperative complications after pancreaticoduodenectomy: a retrospective and propensity score-matched analysis. Pancreatology. 2020;20(3):529-536. https://doi.org/10.1016/j.pan.2020.02.002
Shojaie L, Iorga A, Dara L. Cell death in liver diseases: a review. Int J Mol Sci. 2020;21(24):9682. https://doi. org/10.3390/ijms21249682
Guicciardi ME, Gores GJ. Apoptosis: a mechanism of acute and chronic liver injury. Gut. 2020;54(7):1024-1033. https://doi.org/10.1136/gut.2004.053850
Sodeman T, Bronk SF, Roberts PJ, et al. Bile salts mediate hepatocyte apoptosis by increasing cell surface trafficking of Fas. Am J Physiol Gastrointest Liver Physiol. 2000;278:G992-G999. https://doi.org/10.1152/ajpgi.2000.278.6.G992
Wang K. Molecular mechanisms of hepatic apoptosis. Cell Death Dis. 2014;5(1):e996-e996. https://doi.org/10.1038/ cddis.2013.499
Elsaied N, Samy A, Mosbah E, et al. Induction of surgical obstructive cholestasis in rats: morphological, bio- chemical and immunohistochemical changes. Mansoura Vet Med J. 2020;21(3):107-115. https://doi.org/:10.21608/ mvmj.2020.21.318
Zhang Y, Liu C, Barbier O, et al. Bcl2 is a critical regulator of bile acid homeostasis by dictating Shp and lncRNA H19 function. Sci Rep. 2016;3(6):20559. https://doi.org/:10.1038/srep20559
Nzeako UC, Guicciardi ME, Yoon JH, et al. COX‐2 inhibits Fas‐mediated apoptosis in cholangiocarcinoma cells.
Hepatology. 2002;35(3):552-559. https://doi.org/:10.1053/jhep.2002.31774
Mancini M, Nicholson DW, Roy S, et al. The caspase-3 precursor has a cytosolic and mitochondrial distribution: implications for apoptotic signaling. J Cell Biol. 1998;140(6):1485-1495. https://doi.org/:10.1083/jcb.140.6.1485
Persad R, Liu C, Wu TT, et al. Overexpression of caspase-3 in hepatocellular carcinomas. Mod Pathol. 2004;17(7):861- 867. https://doi.org/:10.1038/modpathol.3800146
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Experimental Oncology

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.